SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31 | -96.8% | 51,794 | -93.0% | 0.00% | -100.0% |
| Q2 2023 | $964 | +13.1% | 741,806 | +53.2% | 0.01% | -10.0% |
| Q1 2023 | $852 | -99.8% | 484,151 | +302.4% | 0.01% | +100.0% |
| Q2 2022 | $498,000 | -12.8% | 120,316 | +57.8% | 0.01% | +66.7% |
| Q4 2021 | $571,000 | +65.5% | 76,247 | +98.6% | 0.00% | +50.0% |
| Q3 2021 | $345,000 | -65.6% | 38,393 | -54.2% | 0.00% | -77.8% |
| Q2 2021 | $1,002,000 | +237.4% | 83,755 | +339.5% | 0.01% | +50.0% |
| Q4 2020 | $297,000 | +206.2% | 19,058 | +84.5% | 0.01% | +100.0% |
| Q3 2020 | $97,000 | -47.3% | 10,329 | -49.2% | 0.00% | -66.7% |
| Q3 2019 | $184,000 | +46.0% | 20,351 | +78.5% | 0.01% | -84.7% |
| Q2 2015 | $126,000 | – | 11,400 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |